The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 353:2640-2641 December 22, 2005 Number 25
NextNext

Tumor-Infiltrating T Cells — Friend or Foe of Neoplastic Cells?
Giorgio Parmiani, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Pagès, F.
-PubMed Citation
During the past 20 years, there have been many reports of the presence of inflammatory and immune-cell infiltrates in various neoplasms, including colorectal cancer. Initially, these findings were thought to indicate that although the immune system can recognize autologous tumor cells, it mounts an ineffective response to them. In the 1990s, functional studies demonstrated the presence of HLA-restricted T cells specific for colorectal cancer in populations of tumor-infiltrating lymphocytes and peripheral-blood mononuclear cells from patients with colorectal cancer. Since there were negligible numbers of such T cells in the blood of control subjects, the findings indicated that some of the . . . [Full Text of this Article]


Source Information

Dr. Parmiani is the chairman of the Unit of Immunotherapy of Human Tumors, Istituto Nazionale Tumori, Milan.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.